Bring discipline to uncertain growth and investment.
Connect market opportunities, portfolio priorities and financial scenarios across pharmaceuticals, biotechnology and life sciences.
Scientific progress and commercial value operate on different timelines. Portfolio decisions need to reflect development uncertainty, funding needs, market alternatives and the sensitivity of future cash flows. Transparent assumptions help leaders compare opportunities without obscuring risk.
Which development and commercial assumptions drive portfolio value?
How do timing, funding and market scenarios affect the investment case?
Where can consistent data improve portfolio reviews and resource allocation?
A practical starting point.
Combine a market and portfolio baseline with driver-based financial models, risk-adjusted valuation and scenario analysis. Decision materials can show how changes in timing, cost and commercial expectations alter funding priorities. Commercial pricing analysis can evaluate product and channel economics using business-provided market and access inputs.
Relevant background
Cella Mlo’s earlier investment-analysis work at 180 Degree Capital included biotechnology and pharmaceutical investments, portfolio valuation, DCF and option-pricing analysis. Consulting experience also includes DSM North America’s venture investment activities.
Pricing Strategy & Revenue Optimization
Understand where value is created, where margin is lost, and which pricing decisions deserve a different approach.
02Tariff Impact & Margin Protection
Connect supplier costs, landed-cost assumptions and customer economics before deciding how to protect margin.
03Commercial Analytics & Predictive Modeling
Bring fragmented commercial and operating data into models that explain performance and support forward-looking decisions.
04Financial Modeling & Valuation
Evaluate investments, contracts and strategic alternatives with transparent financial models and disciplined scenario analysis.
05Automation & Decision Support
Connect repeatable financial processes, exception reporting and decision workflows through practical automation.
What’s your next
commercial decision?
Bring us the challenge. We’ll discuss the data, the decisions and a practical scope of work.
Discuss Your Business Challenge